BioWorld Asia

Sep. 26, 2007

Study Shows European Biotech Investments Lagging Behind U.S.

BRUSSELS, Belgium - European biotechnology companies are being outpaced by their U.S. competitors in research investments and in the scale of their operations, according to a new study from the European Union. (BioWorld International) Read More

NIH Trial Of Diabetes Vaccine Boosts Shares Of Diamyd

New Selection Technique Signals Progress Toward Cell Therapy

Researchers Call Animal Models Biased In Stroke Assessments

Biolipox Gets Inflazyme Pipeline For C$4 Million Plus Milestones

Polyplus-transfection Enters RNAi Deal With Alnylam Pharma

Other News To Note

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for March 30, 2026.

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026